An observational, multicenter study assessing trends in daily mood, pain, and fatigue among participants in the MADELINE study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

03 Oct 2020 Results assessing impact of advanced or metastatic breast cancer or its treatment on productivity, energy, and physical activity among palbociclib participants of the MADELINE Study, presented at the Official 12th European Breast Cancer Conference
31 May 2020 Results assessing effect of neutropenia on patient-reported functioning and quality of life (QOL) among palbociclib participants, presented at the 56th Annual Meeting of the American Society of Clinical Oncology.
21 Jan 2020 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com